Vagif Atduev
YOU?
Author Swipe
View article: 1Pembrolizumab plus lenvatinib for previously untreated advanced non–clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study
1Pembrolizumab plus lenvatinib for previously untreated advanced non–clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study Open
Background First-line pembrolizumab plus lenvatinib showed durable responses in participants with advanced non–clear cell renal cell carcinoma (nccRCC) in the single-arm, phase 2 KEYNOTE-B61 study (NCT04704219). Responses were observed acr…
View article: Analysis of content of thermal decomposition products of urine at prostate cancer and benign prostatic hyperplasia by terahertz nonstationary gas spectroscopy
Analysis of content of thermal decomposition products of urine at prostate cancer and benign prostatic hyperplasia by terahertz nonstationary gas spectroscopy Open
The work is devoted to studying the metabolites composition for human urine of prostate cancer and benign prostatic hyperplasia patients by terahertz (THz) high-resolution gas spectroscopy. The comparison of the composition of metabolites …
View article: Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011 Open
Background First‐line pembrolizumab monotherapy is a standard of care for platinum‐ineligible patients with advanced urothelial carcinoma (UC). No global standardized definition of platinum ineligibility exists. This study aimed to evaluat…
View article: Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer Open
Perioperative durvalumab plus neoadjuvant chemotherapy led to significant improvements in event-free survival and overall survival as compared with neoadjuvant chemotherapy alone. (Funded by AstraZeneca; NIAGARA ClinicalTrials.gov number, …
View article: Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM)
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM) Open
Background. Prostate cancer (PCa) is one of the most common cancers of men. In 2022, 48,025 new PCa cases and 12,896 deaths from the disease were reported in Russia. Metastatic castration-resistant PCa still is one of the common causes of …
View article: Application of High-Resolution Terahertz Gas Spectroscopy for Studying the Composition of Thermal Decomposition Products in Human Urine of Prostate Cancer Patients
Application of High-Resolution Terahertz Gas Spectroscopy for Studying the Composition of Thermal Decomposition Products in Human Urine of Prostate Cancer Patients Open
The results of using nonstationary high-resolution THz spectroscopy for detecting a characteristic set of metabolites of thermal decomposition products of urine from prostate cancer patients, aimed at identifying specific markers, are pres…
View article: 1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011 Open
View article: An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice
An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice Open
Background. Prostate cancer (PCa) is an actual disease and a frequent oncological pathology in men. The main methods of radical treatment of patients with PCa are radical prostatectomy and radiation therapy. Radical prostatectomy s the mos…
View article: Percutaneous nephrolitholapaxy performed under ultrasound and endovisual guidance: evaluation of the factors affecting the immediate outcomes
Percutaneous nephrolitholapaxy performed under ultrasound and endovisual guidance: evaluation of the factors affecting the immediate outcomes Open
Introduction. In recent years, ultrasound and endovisual guidance have been introduced into clinical practice when performing percutaneous nephrolitholapaxy. Objective. To identify the most significant factors that influence the frequency …
View article: Review of the article “Evaluation of the functional results and safety of early removal of the urethral catheter after laparoscopic radical prostatectomy”
Review of the article “Evaluation of the functional results and safety of early removal of the urethral catheter after laparoscopic radical prostatectomy” Open
.
View article: First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.
First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study. Open
432 Background: Pembro monotherapy is a standard of care for advanced urothelial carcinoma (UC) and showed antitumor activity and acceptable safety when combined with lenva in the phase 1b/2 KEYNOTE-146 study. We present results of LEAP-01…
View article: Long-term functional results of orthotopic urinary derivation by Studer and VIP after radical cystectomy in women
Long-term functional results of orthotopic urinary derivation by Studer and VIP after radical cystectomy in women Open
View article: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial Open
Background: The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men with prostate cancer and known atherosclerotic cardiovascular disease remains controversial. Methods: In…
View article: Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial Open
View article: Function of the orthotopic urinary reservoir formed from the ileocecal angle in the long term after radical cystectomy in women
Function of the orthotopic urinary reservoir formed from the ileocecal angle in the long term after radical cystectomy in women Open
Objective: to study the long-term functional results of creating an orthotopic urinary reservoir from the ileocecal angle in comparison with the Studer technique of creating a urinary reservoir after radical cystectomy in women.Materials a…
View article: Long-term functional results of orthotopic urinary derivation by Studer and VIP after radical cystectomy in women
Long-term functional results of orthotopic urinary derivation by Studer and VIP after radical cystectomy in women Open
Introduction . The feasibility of reconstructing an orthotopic urinary reservoir after radical cystectomy (RCE) in women is still debatable. This is due to the peculiarities of the physiology and anatomy of the female lower urinary tract a…
View article: The role of infection in the development of complications after radical cystectomy
The role of infection in the development of complications after radical cystectomy Open
View article: Surgical treatment of kidney cancer with extended inferior vena cava thrombosis: complications and long-term results
Surgical treatment of kidney cancer with extended inferior vena cava thrombosis: complications and long-term results Open
Objective. Analysis of factors affecting results of inferior vena cava (IVC) thrombectomy in patients with renal cell carcinoma.Materials and methods. Nephrectomy with thrombectomy from IVC was performed in 53 patients (31 (58.5 %) males a…
View article: Thirty-day complications of radical cystectomy and factors that influence their development
Thirty-day complications of radical cystectomy and factors that influence their development Open
Objective: to identify the most important factors influencing the development of complications after radical cystectomy (RCE).Materials and methods. The results of 182 RCEs performed in September 2014 and December 2016 were analyzed. The p…
View article: Structure of 90 day complications after solitary kidney resection due to parenchyma tumors
Structure of 90 day complications after solitary kidney resection due to parenchyma tumors Open
Objective. Study of 90 day complications after solitary kidney resection and determination of their dependence on resection complexity level in accordance with the RENAL nephrometry scoring system.Materials and methods. Seventy (70) resect…
View article: Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer
Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer Open
Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer.